Cipla

Lanreotide

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / Lanreotide – J1932

Manufacturer:

Cipla

Name:

Lanreotide

HCPCS Code Descriptor:

Injection, lanreotide, (cipla), 1 mg

Category:

J Code

HCPCS:

J1932

NDC(s):

69097-0870-67

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

Lanreotide is an Oncology drug manufactured by Cipla and administered via the Subcutaneous route of administration. The J Code: J1932 is aligned to the drug Lanreotide.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

10/1/22

HCPCS Effective Date:

10/1/22

HCPCS Short Description:

Inj, lanreotide, (cipla) 1mg

Billing and Coding Guide:

Not Found

Patient Assistance:

http://www.ipsencares.com/

Lanreotide - J1932